Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

All-oral direct antiviral treatment for hepatitis C chronic infection in a real-life cohort: The role of cirrhosis and comorbidities in treatment response.

Miotto N, Mendes LC, Zanaga LP, Lazarini MSK, Goncales ESL, Pedro MN, Goncales FL Jr, Stucchi RSB, Vigani AG.

PLoS One. 2018 Jul 10;13(7):e0199941. doi: 10.1371/journal.pone.0199941. eCollection 2018.

2.

Predictors of early discontinuation of interferon-free direct antiviral agents in patients with hepatitis C virus and advanced liver fibrosis: results of a real-life cohort.

Miotto N, Mendes LC, Zanaga LP, Goncales ESL, Lazarini MSK, Pedro MN, Gonçales FL Jr, Stucchi RSB, Vigani AG.

Eur J Gastroenterol Hepatol. 2017 Oct;29(10):1149-1154. doi: 10.1097/MEG.0000000000000944.

PMID:
28800033
3.

Predictors of early treatment discontinuation and severe anemia in a Brazilian cohort of hepatitis C patients treated with first-generation protease inhibitors.

Miotto N, Mendes LC, Zanaga LP, Goncales ES, Lazarini MS, Pedro MN, Goncales FL Jr, Stucchi RS, Vigani AG.

Braz J Med Biol Res. 2016 Jun 23;49(7). pii: S0100-879X2016000700702. doi: 10.1590/1414-431X20165300.

4.

Strategies to manage hepatitis C virus (HCV) disease burden.

Wedemeyer H, Duberg AS, Buti M, Rosenberg WM, Frankova S, Esmat G, Örmeci N, Van Vlierberghe H, Gschwantler M, Akarca U, Aleman S, Balık I, Berg T, Bihl F, Bilodeau M, Blasco AJ, Brandão Mello CE, Bruggmann P, Calinas F, Calleja JL, Cheinquer H, Christensen PB, Clausen M, Coelho HS, Cornberg M, Cramp ME, Dore GJ, Doss W, El-Sayed MH, Ergör G, Estes C, Falconer K, Félix J, Ferraz ML, Ferreira PR, García-Samaniego J, Gerstoft J, Giria JA, Gonçales FL Jr, Guimarães Pessôa M, Hézode C, Hindman SJ, Hofer H, Husa P, Idilman R, Kåberg M, Kaita KD, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marinho RT, Marotta P, Mauss S, Mendes Correa MC, Moreno C, Müllhaupt B, Myers RP, Nemecek V, Øvrehus AL, Parkes J, Peltekian KM, Ramji A, Razavi H, Reis N, Roberts SK, Roudot-Thoraval F, Ryder SD, Sarmento-Castro R, Sarrazin C, Semela D, Sherman M, Shiha GE, Sperl J, Stärkel P, Stauber RE, Thompson AJ, Urbanek P, Van Damme P, van Thiel I, Vandijck D, Vogel W, Waked I, Weis N, Wiegand J, Yosry A, Zekry A, Negro F, Sievert W, Gower E.

J Viral Hepat. 2014 May;21 Suppl 1:60-89. doi: 10.1111/jvh.12249.

PMID:
24713006
5.

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm.

Razavi H, Waked I, Sarrazin C, Myers RP, Idilman R, Calinas F, Vogel W, Mendes Correa MC, Hézode C, Lázaro P, Akarca U, Aleman S, Balık I, Berg T, Bihl F, Bilodeau M, Blasco AJ, Brandão Mello CE, Bruggmann P, Buti M, Calleja JL, Cheinquer H, Christensen PB, Clausen M, Coelho HS, Cramp ME, Dore GJ, Doss W, Duberg AS, El-Sayed MH, Ergör G, Esmat G, Falconer K, Félix J, Ferraz ML, Ferreira PR, Frankova S, García-Samaniego J, Gerstoft J, Giria JA, Gonçales FL Jr, Gower E, Gschwantler M, Guimarães Pessôa M, Hindman SJ, Hofer H, Husa P, Kåberg M, Kaita KD, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Marinho RT, Marotta P, Mauss S, Moreno C, Murphy K, Negro F, Nemecek V, Örmeci N, Øvrehus AL, Parkes J, Pasini K, Peltekian KM, Ramji A, Reis N, Roberts SK, Rosenberg WM, Roudot-Thoraval F, Ryder SD, Sarmento-Castro R, Semela D, Sherman M, Shiha GE, Sievert W, Sperl J, Stärkel P, Stauber RE, Thompson AJ, Urbanek P, Van Damme P, van Thiel I, Van Vlierberghe H, Vandijck D, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Cornberg M, Müllhaupt B, Estes C.

J Viral Hepat. 2014 May;21 Suppl 1:34-59. doi: 10.1111/jvh.12248.

PMID:
24713005
6.

Historical epidemiology of hepatitis C virus (HCV) in selected countries.

Bruggmann P, Berg T, Øvrehus AL, Moreno C, Brandão Mello CE, Roudot-Thoraval F, Marinho RT, Sherman M, Ryder SD, Sperl J, Akarca U, Balık I, Bihl F, Bilodeau M, Blasco AJ, Buti M, Calinas F, Calleja JL, Cheinquer H, Christensen PB, Clausen M, Coelho HS, Cornberg M, Cramp ME, Dore GJ, Doss W, Duberg AS, El-Sayed MH, Ergör G, Esmat G, Estes C, Falconer K, Félix J, Ferraz ML, Ferreira PR, Frankova S, García-Samaniego J, Gerstoft J, Giria JA, Gonçales FL Jr, Gower E, Gschwantler M, Guimarães Pessôa M, Hézode C, Hofer H, Husa P, Idilman R, Kåberg M, Kaita KD, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marotta P, Mauss S, Mendes Correa MC, Müllhaupt B, Myers RP, Negro F, Nemecek V, Örmeci N, Parkes J, Peltekian KM, Ramji A, Razavi H, Reis N, Roberts SK, Rosenberg WM, Sarmento-Castro R, Sarrazin C, Semela D, Shiha GE, Sievert W, Stärkel P, Stauber RE, Thompson AJ, Urbanek P, van Thiel I, Van Vlierberghe H, Vandijck D, Vogel W, Waked I, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Van Damme P, Aleman S, Hindman SJ.

J Viral Hepat. 2014 May;21 Suppl 1:5-33. doi: 10.1111/jvh.12247. Review.

PMID:
24713004
7.

A global view of hepatitis C: physician knowledge, opinions, and perceived barriers to care.

McGowan CE, Monis A, Bacon BR, Mallolas J, Goncales FL, Goulis I, Poordad F, Afdhal N, Zeuzem S, Piratvisuth T, Marcellin P, Fried MW.

Hepatology. 2013 Apr;57(4):1325-32. doi: 10.1002/hep.26246.

8.

Therapeutic effectiveness of biosimilar standard interferon versus pegylated interferon for chronic hepatitis C genotypes 2 or 3.

Vigani AG, Gonçales ES, Pavan MH, Genari F, Tozzo R, Lazarini MS, Fais V, Feltrin A, Gonçales NS, Gonçales FL Jr.

Braz J Infect Dis. 2012 May-Jun;16(3):232-6.

9.

Virus C genotype predisposes to primary hypothyroidism during interferon-α treatment for chronic hepatitis C.

Pavan MH, Pavin EJ, Gonçales FL Jr, Zantut-Wittmann DE, Wittmann DE.

Braz J Infect Dis. 2011 Sep-Oct;15(5):449-56. Erratum in: Braz J Infect Dis. 2013 Jan-Feb;17(1):122. Wittmann, Denise Engelbrecht Zantut [corrected to Zantut-Wittmann, Denise E].

10.

Central hypothyroidism in patients with chronic hepatitis C and relation with interferon-alpha treatment.

Zantut-Wittmann DE, Pavan MH, Pavin EJ, Goncales FL Jr.

Endocr Regul. 2011 Jul;45(3):157-61.

PMID:
21793628
11.

Trends and projections of hepatitis C virus epidemiology in Latin America.

Kershenobich D, Razavi HA, Sánchez-Avila JF, Bessone F, Coelho HS, Dagher L, Gonçales FL, Quiroz JF, Rodriguez-Perez F, Rosado B, Wallace C, Negro F, Silva M.

Liver Int. 2011 Jul;31 Suppl 2:18-29. doi: 10.1111/j.1478-3231.2011.02538.x. Review.

PMID:
21651701
12.

The association of cryoglobulinaemia with sustained virological response in patients with chronic hepatitis C.

Vigani AG, Macedo de Oliveira A, Tozzo R, Pavan MH, Gonçales ES, Fais V, Gonçales NS, Gonçales FL.

J Viral Hepat. 2011 Apr;18(4):e91-8. doi: 10.1111/j.1365-2893.2010.01385.x. Epub 2010 Oct 25.

PMID:
20969676
13.

Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?

Gonçales FL Jr, Moma CA, Vigani AG, Angerami AF, Gonçales ES, Tozzo R, Pavan MH, Gonçales NS.

BMC Infect Dis. 2010 Jul 20;10:212. doi: 10.1186/1471-2334-10-212.

14.

Extended treatment with interferon and ribavirin in a hemodialysis patient with chronic hepatitis C.

Vigani AG, Pavan MH, Tozzo R, Gonçales ES, Lazarini MS, Oliveira AM, Gonçales FL Jr.

Braz J Infect Dis. 2010 Mar-Apr;14(2):193-6.

15.

Hepatitis B virus: molecular genotypes and HBeAg serological status among HBV-infected patients in the southeast of Brazil.

Tonetto PA, Gonçales NS, Fais VC, Vigani AG, Gonçales ES, Feltrin A, Gonçales FL Jr.

BMC Infect Dis. 2009 Sep 8;9:149. doi: 10.1186/1471-2334-9-149.

16.

Comparative study of patients with chronic hepatitis C virus infection due to genotypes 1 and 3 referred for treatment in southeast Brazil.

Vigani AG, Pavan MH, Tozzo R, Gonçales ES, Feltrin A, Fais VC, Lazarini MS, Gonçales NS, Gonçales FL Jr.

BMC Infect Dis. 2008 Dec 4;8:164. doi: 10.1186/1471-2334-8-164.

17.

Distribution of the human leukocyte antigen class II alleles in Brazilian patients with chronic hepatitis C virus infection.

Corghi DB, Gonçales NS, Marques SB, Gonçales FL Jr.

Braz J Med Biol Res. 2008 Oct;41(10):884-9. Epub 2008 Sep 30.

18.

Prevalence of transfusion-transmitted Chagas Disease among multitransfused patients in Brazil.

De Paula EV, Goncales NS, Xueref S, Addas-Carvalho M, Gilli SC, Angerami RN, Goncales FL Jr.

BMC Infect Dis. 2008 Jan 16;8:5. doi: 10.1186/1471-2334-8-5.

19.

Consensus of the Brazilian Society of Infectious Diseases on the management and treatment of hepatitis C.

de Araújo ES, Mendonça JS, Barone AA, Gonçales FL Jr, Ferreira MS, Focaccia R, Pawlotsky JM.

Braz J Infect Dis. 2007 Oct;11(5):446-50. No abstract available.

PMID:
17962867
20.

Weight-based combination therapy with peginterferon alpha-2b and ribavirin for naïve, relapser and non-responder patients with chronic hepatitis C.

Gonçales FL Jr, Vigani A, Gonçales N, Barone AA, Araújo E, Focaccia R, Oliveira U, Coelho HS, Paixao J, Perez R, Lobato C, Weirich J, Rosa H, Borges A, Vila R, Corrêa-Giannella ML, Ferraz ML.

Braz J Infect Dis. 2006 Oct;10(5):311-6.

PMID:
17293917
21.

Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users.

Morice Y, Cantaloube JF, Beaucourt S, Barbotte L, De Gendt S, Goncales FL, Butterworth L, Cooksley G, Gish RG, Beaugrand M, Fay F, Fay O, Gonzalez JE, Martins RM, Dhumeaux D, Vanderborght B, Stuyver L, Sablon E, de Lamballerie X, Pawlotsky JM.

J Med Virol. 2006 Oct;78(10):1296-303.

PMID:
16927280
22.

Re-treatment of chronic hepatitis C patients after relapse: efficacy of peginterferon-alpha-2a (40 kDa) and ribavirin.

Berg C, Goncales FL Jr, Bernstein DE, Sette H Jr, Rasenack J, Diago M, Jensen DM, Graham P, Cooksley G.

J Viral Hepat. 2006 Jul;13(7):435-40.

PMID:
16792536
23.

Transfusion-transmitted infections among multi-transfused patients in Brazil.

de Paula EV, Gonçales NS, Xueref S, Addas-Carvalho M, Gilli SC, Angerami RN, Veríssimo MP, Gonçales FL Jr.

J Clin Virol. 2005 Dec;34 Suppl 2:S27-32.

PMID:
16461237
24.

Hepatitis C virus infection, cryoglobulinemia, and peripheral neuropathy: a case report.

Vigani AG, Macedo-de-Oliveira A, Pavan MH, Pedro MN, Gonçales FL Jr.

Braz J Med Biol Res. 2005 Dec;38(12):1729-34. Epub 2005 Nov 9. Review.

25.

Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin.

Ferenci P, Fried MW, Shiffman ML, Smith CI, Marinos G, Gonçales FL Jr, Häussinger D, Diago M, Carosi G, Dhumeaux D, Craxì A, Chaneac M, Reddy KR.

J Hepatol. 2005 Sep;43(3):425-33.

PMID:
15990196
26.

The influence of occult infection with hepatitis B virus on liver histology and response to interferon treatment in chronic hepatitis C patients.

Silva Cd, Gonçales NS, Pereira JS, Escanhoela CA, Pavan MH, Gonçales FL Jr.

Braz J Infect Dis. 2004 Dec;8(6):431-9. Epub 2005 May 9.

PMID:
15880234
27.

Demographic and anthropometrical analysis and genotype distribution of chronic hepatitis C patients treated in public and private reference centers in Brazil.

Focaccia R, Baraldo DC, Ferraz ML, Martinelli AL, Carrilho FJ, Gonçales FL Jr, Pedroso ML, Coelho HS, Lacerda MA, Brandão CE, Mattos AA, Lira LG, Zamin I Jr, Pinheiro JO, Tovo CV, Both CT, Soares JA, Dittrich S.

Braz J Infect Dis. 2004 Oct;8(5):348-55. Epub 2005 Mar 17.

PMID:
15798810
28.

Hepatitis B virus DNA in sera of blood donors and of patients infected with hepatitis C virus and human immunodeficiency virus.

Gonçales FL Jr, Pereira JS, Da Silva C, Thomaz GR, Pavan MH, Fais VC, Magna LA, Gonçales NS.

Clin Diagn Lab Immunol. 2003 Jul;10(4):718-20.

29.

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.

Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gonçales FL Jr, Häussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J.

N Engl J Med. 2002 Sep 26;347(13):975-82.

31.

Hepatitis C virus in monozygotic twins.

Gonçales FL Jr, Stucchi RS, Pavan MH, Angerami RN, Gonçales NS.

Rev Inst Med Trop Sao Paulo. 2000 May-Jun;42(3):163-5.

32.

A clinical, epidemological, laboratorial, histological and ultrasonographical evaluation of anti-HCV EIA-2 positive blood donors.

Gonçales FL Jr, Stucchi RS, Pavan MH, Escanhoela CA, Yamanaka A, Magna LA, Gonçales NS.

Rev Inst Med Trop Sao Paulo. 2000 May-Jun;42(3):147-52.

33.

High prevalence of GB virus C in Brazil and molecular evidence for intrafamilial transmission.

Pinho JR, Zanotto PM, Ferreira JL, Sumita LM, Carrilho FJ, da Silva LC, Capacci ML, Silva AO, Guz B, Gonçales FL Jr, Gonçales NS, Buck GA, Meyers GA, Bernardini AP.

J Clin Microbiol. 1999 May;37(5):1634-7.

Supplemental Content

Loading ...
Support Center